The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines Quick Links Resources Research & Education Vaccine Injuries Vaers Patient Experience
